Best of the Blog, IN VIVO, November 2009
Executive Summary
A selection of our favorite blog posts from November 2009 about stories not covered elsewhere in this issue of IN VIVO. (See the original postings for free at http://invivoblog.blogspot.com/).
You may also be interested in...
FDA Updates Plavix Label, Leaves Effient With Clear Advantage
FDA expands upon the warning that it discreetly slipped into the anti-clotting drug's labeling in May, with new data that clopidogrel is 50% less effective when given with Prilosec.
Medco "Genetics For Generics" Research Anticipates Plavix Patent Loss
Medco is working to generate cost effectiveness data for Bristol-Myers Squibb's anti-clotting blockbuster Plavix in anticipation of the launch of clopidogrel generics in 2011
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.